Evidence map›Paper›PMID 36115991›Full record

ArticleOrphanet journal of rare diseases2022

Identification and in silico analysis of a spectrum of SLC4A11 variations in Indian familial and sporadic cases of congenital hereditary endothelial dystrophy.

Mohd Salman, Anshuman Verma, Sunita Chaurasia, Deeksha Prasad, Chitra Kannabiran, Vivek Singh, Muralidhar Ramappa

Erratum issuedOpen access · goldAbstract readCase Reports
In one paragraph

Article in Orphanet journal of rare diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Biomolecules · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Mohd Salman *Prof. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L V Prasad Eye Institute, Hyderabad, India.
Anshuman Verma *Prof. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L V Prasad Eye Institute, Hyderabad, India.
Sunita ChaurasiaCentre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, India.
Deeksha PrasadProf. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L V Prasad Eye Institute, Hyderabad, India.
Chitra KannabiranCentre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, India.
Vivek SinghProf. Brien Holden Eye Research Center, Champalimaud Translational Centre for Eye Research, L V Prasad Eye Institute, Hyderabad, India. viveksingh@lvpei.org.
Muralidhar RamappaCentre for Rare Eye Diseases and Ocular Genetics, L V Prasad Eye Institute, Hyderabad, India. muralidhar@lvpei.org.ORCID http://orcid.org/0000-0003-3667-5483
L V Prasad Eye Institute · INManipal Academy of Higher Education · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCongenital hereditary endothelial dystrophy (CHED) is a rare form of corneal dystrophy caused by SLC4A11 gene variations. This study aims to find the genetic alterations in SLC4A11, in two Indian familial CHED cases with affected members n = 3 and n = 2 respectively and five sporadic CHED cases using direct sequencing, followed by in silico analysis and characterization of the identified variants.

resultsAll three affected members of the first CHED family were identified with a novel homozygous c.1514C > G (p.Ser489Trp) variation while second family showed presence of a compound heterozygous variation c.529A > C (p.Arg161Arg) + c.2461insT (p.Val805fs). Among five sporadic cases, two showed novel changes, homozygous c.1487G > T (p.Ser480Ile) and c.620-2A > G, while the other one had previously reported homozygous c.2653C > T (p.Arg869Cys) variation. The remaining two cases did not reveal the presence of SLC4A11-related pathogenic variations. The identified variations were excluded from the Indian control (n = 80). In silico analysis using homology-based protein modeling and pathogenicity prediction tools, which revealed these alterations as pathogenic, changing their protein stability, local flexibility, residue contact clashes, and the hydrogen bond interactions.

conclusionsThis study contributed to the CHED mutational spectrum, adding four novel variations and confirming a previously reported one. It demonstrates different type of variations in CHED cases, including coding, non-coding, homozygous, synonymous, and compound heterozygous variations. The identified variations revealed different degrees of pathogenic effects in silico. Moreover, two sporadic cases could not be identified with pathogenic variation emphasizing the involvement of other genes or genetic mechanisms.

Indexed as

Anion Transport ProteinsAntiportersCorneal Dystrophies, HereditaryHomozygoteHumansIndiaMutationAnion Transport ProteinsAntiportersSLC4A11 protein, humanCHEDCorneal dystrophySLC4A11Variations

Identifiers

PMID36115991
PMCPMC9482203
OpenAlexW4296249148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.